Resultats de la cerca - Massimo Massaia
- Mostrar 1 - 20 resultats de 28
- Anar a la pàgina següent
-
1
-
2
Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule per Antonella Chillemi, Gianluca Zaccarello, Valeria Quarona, Manuela Ferracin, Chiara Ghimenti, Massimo Massaia, Alberto L. Horenstein, Fabio Malavasi
Publicat 2013Revisão -
3
Management of chimeric antigen receptor T-cell-related toxicity of a patient affected by cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, follo... per G Menardi, Alessia Castellino, Claudia Castellino, M. E. Bersia, Enrique Grande, G. Fraternali, Massimo Massaia, C Fruttero
Publicat 2025Artigo -
4
Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease per R. Foà, Massimo Massaia, S Cardona, AG Tos, Andrea Bianchi, C Attisano, Anna Guarini, PF di Celle, Mt Fierro
Publicat 1990Artigo -
5
Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells per Chiara Riganti, Barbara Castella, Joanna Kopecka, Ivana Campia, Marta Coscia, Gianpiero Pescarmona, Amalia Bosìa, Dario Ghigo, Massimo Massaia
Publicat 2013Artigo -
6
Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease per R. Foà, Massimo Massaia, S Cardona, AG Tos, Alberto Bianchi, C Attisano, Anna Guarini, PF di Celle, Mt Fierro
Publicat 1990Artigo -
7
Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. per Massimo Massaia, Lionel Perrin, Alberto Bianchi, J M Ruedi, C Attisano, Dario C. Altieri, G T Rijkers, L F Thompson
Publicat 1990Artigo -
8
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid per Francesca Fiore, Barbara Castella, Barbara Nuschak, Raffaello Bertieri, Sara Mariani, Benedetto Bruno, Francesca Pantaleoni, Myriam Foglietta, Mario Boccadoro, Massimo Massaia
Publicat 2007Artigo -
9
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells per Barbara Castella, Joanna Kopecka, Patrizia Sciancalepore, Giorgia Mandili, Myriam Foglietta, Nico Mitro, Donatella Caruso, Francesco Novelli, Chiara Riganti, Massimo Massaia
Publicat 2017Artigo -
10
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between Vγ9Vδ2 T Cells, αβ CD8+ T Cells, Regulatory T Cells, and Dendritic Cells per Barbara Castella, Chiara Riganti, Francesca Fiore, Francesca Pantaleoni, Maria Elisa Canepari, Silvia Peola, Myriam Foglietta, Antonio Palumbo, Amalia Bosìa, Marta Coscia, Mario Boccadoro, Massimo Massaia
Publicat 2011Artigo -
11
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and... per Fabio Morandi, Danilo Marimpietri, Alberto L. Horenstein, Marina Bolzoni, Denise Toscani, Federica Costa, Barbara Castella, Angelo Corso Faini, Massimo Massaia, Vito Pistoia, Nicola Giuliani, Fabio Malavasi
Publicat 2018Artigo -
12
Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway per Marta Coscia, Elena Quaglino, Manuela Iezzi, Claudia Curcio, Francesca Pantaleoni, Chiara Riganti, Ingunn Holen, Hannu Mönkkönen, Mario Boccadoro, Guido Forni, Piero Musiani, Amalia Bosìa, Federica Cavallo, Massimo Massaia
Publicat 2009Artigo -
13
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells per Marta Coscia, Francesca Pantaleoni, Chiara Riganti, Candida Vitale, Micol Maria Rigoni, Silvia Peola, Barbara Castella, Myriam Foglietta, Valentina Griggio, Daniela Drandi, Marco Ladetto, Amalia Bosìa, Mario Boccadoro, Massimo Massaia
Publicat 2011Artigo -
14
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma per Barbara Castella, Myriam Foglietta, Patrizia Sciancalepore, Micol Maria Rigoni, Marta Coscia, Valentina Griggio, Candida Vitale, Riccardo Ferracini, Elona Saraci, Paola Omedè, Chiara Riganti, Antonio Palumbo, Mario Boccadoro, Massimo Massaia
Publicat 2015Artigo -
15
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells per Antonio Curti, Simona Pandolfi, Barbara Valzasina, Michela Aluigi, Alessandro Isidori, Elisa Ferri, Valentina Salvestrini, Giuseppina Bonanno, Sergio Rutella, Ilaria Durelli, Alberto L. Horenstein, Francesca Fiore, Massimo Massaia, Mario P. Colombo, Michele Baccarani, Roberto M. Lemoli
Publicat 2006Artigo -
16
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells per Marta Coscia, Candida Vitale, Silvia Peola, Myriam Foglietta, Micol Maria Rigoni, Valentina Griggio, Barbara Castella, Daniela F. Angelini, Sabina Chiaretti, Chiara Riganti, Anna Guarini, Daniela Drandi, Marco Ladetto, Amalia Bosìa, Robin Foà, Luca Battistini, Mario Boccadoro, Jean‐Jacques Fournié, Massimo Massaia
Publicat 2012Artigo -
17
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia per Davide Rossi, Chiara Lobetti Bodoni, Elisa Genuardi, Luigia Monitillo, Daniela Drandi, M Cerri, Clara Deambrogi, Irene Ricca, Alberto Rocci, Simone Ferrero, Elisa Bernocco, Daniela Capello, Lorenzo De Paoli, L Bergui, Michela Boi, Paola Omedè, Massimo Massaia, Corrado Tarella, Roberto Passera, Mario Boccadoro, Gianluca Gaïdano, Marco Ladetto
Publicat 2009Artigo -
18
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma per Luisa Giaccone, Barry E. Storer, Francesca Patriarca, Marcello Rotta, Roberto Sorasio, Bernardino Allione, Fabrizio Carnevale‐Schianca, Moreno Festuccia, Lucia Brunello, Paola Omedè, Sara Bringhen, Massimo Aglietta, Alessandro Levis, Nicola Mordini, Andrea Gallamini, Renato Fanin, Massimo Massaia, Antonio Palumbo, Giovannino Ciccone, Rainer Storb, Ted Gooley, Mario Boccadoro, Benedetto Bruno
Publicat 2011Artigo -
19
Melphalan 200 mg/m2 versus melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study per Antonio Palumbo, Sara Bringhen, Benedetto Bruno, Antonietta Falcone, Anna Marina Liberati, Mariella Grasso, Roberto Ria, Francesco Pisani, Clotilde Cangialosi, Tommaso Caravita, Anna Levi, Giovanna Meloni, Andrea Nozza, Patrizia Pregno, A. Gabbas, Vincenzo Callea, Manuela Rizzo, Luciana Annino, Valerio De Stefano, Pellegrino Musto, Ileana Baldi, Federica Cavallo, Maria Teresa Petrucci, Massimo Massaia, Mario Boccadoro
Publicat 2009Artigo -
20
HIF-1α is over-expressed in leukemic cells from <i>TP53</i>-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia per Valentina Griggio, Candida Vitale, Maria Chiara Todaro, Chiara Riganti, Joanna Kopecka, Chiara Salvetti, Riccardo Bomben, Michele Dal Bo, Daniela Magliulo, Davide Rossi, Gabriele Pozzato, Lisa Bonello, Monia Marchetti, Paola Omedè, Ahad Ahmed Kodipad, Luca Laurenti, Giovanni Del Poeta, Francesca Romana Mauro, Rosa Bernardi, Thorsten Zenz, Valter Gattei, Gianluca Gaïdano, Robin Foà, Massimo Massaia, Mario Boccadoro, Marta Coscia
Publicat 2019Artigo
Eines de cerca:
Matèries relacionades
Biology
Medicine
Immunology
Internal medicine
Cancer research
Biochemistry
Chemistry
Chronic lymphocytic leukemia
Leukemia
Cell biology
Immune system
Oncology
Multiple myeloma
Antibody
Chemotherapy
Gene
T cell
Cancer
Cytotoxic T cell
Gastroenterology
In vitro
Lymphoma
Molecular biology
Receptor
Antigen
Biosynthesis
Bone marrow
Cyclophosphamide
Cytokine
Enzyme